Daniella Beckman, Chief Financial Officer at Tango Therapeutics, Inc. (TNGX), sold 3,725 shares at $12.56 ($47K) on 2024-02-06, disclosed to the SEC on 2024-02-08.
Open-market sale of $47k TNGX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.56 | 1,908 | $24K | 51.1% |
| 2 | $12.62 | 1,817 | $23K | 48.9% |
| Total | $12.59 avg | 3,725 | $47K | 100% |
| Filing → |